Institutional investors purchased a net $22.0 million shares of MRNA during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 52.68% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
COATUE MANAGEMENT LLC Bought 4.9 Million shares of Moderna Inc
LONE PINE CAPITAL LLC Bought 4.0 Million shares of Moderna Inc
D. E. SHAW & CO. LP Bought 1.6 Million shares of Moderna Inc